ASTH vs PRVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

ASTH

48.7
AI Score
VS
ASTH Wins

PRVA

48.2
AI Score

Investment Advisor Scores

ASTH

49score
Recommendation
HOLD

PRVA

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH PRVA Winner
Forward P/E 9.5602 19.4553 ASTH
PEG Ratio 0 0 Tie
Revenue Growth 48.5% 21.4% ASTH
Earnings Growth 110.5% 250.0% PRVA
Tradestie Score 48.7/100 48.2/100 ASTH
Profit Margin 1.1% 1.2% PRVA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ASTH 1M: -16.2% · 3M: -10.1% PRVA 1M: +13.6% · 3M: +13.1%

Current Technical Phase

ASTH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 34

RSI (14): 33.7 · Price: $32.18

PRVA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 71

RSI (14): 70.7 · Price: $24.37

Fundamentals Snapshot

Metric ASTH PRVA
Market Cap — —
Forward P/E 8.9 23.7
Trailing P/E 31.9 94.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 1.06 0.26
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.